A patient is scheduled to receive Pergonal (Menotropins) injections as part of an infertility treatment before in vitro fertilization.
What is the anticipated effect of this medication?
Extension of the luteal phase.
Induction of ovulation.
Inhibition of menstruation.
Enhancement of cervical mucus production.
The Correct Answer is B
Choice A rationale
Pergonal (Menotropins) does not extend the luteal phase. The luteal phase is a part of the menstrual cycle, and Pergonal does not have a direct effect on this phase.
Choice B rationale
Pergonal (Menotropins) is used to induce ovulation in women as part of an infertility treatment before in vitro fertilization. It contains follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which stimulate the ovaries to produce eggs.
Choice C rationale
Pergonal (Menotropins) does not inhibit menstruation. It is used to stimulate the ovaries to produce eggs, not to stop the menstrual cycle.
Choice D rationale
Pergonal (Menotropins) does not enhance cervical mucus production. Its primary function is to stimulate the ovaries to produce eggs.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is C
Explanation
Choice A rationale
As of my knowledge cutoff in 2021, there is no vaccine available that prevents genital herpes simplex infection from returning.
Choice B rationale
Penicillin is not effective against viral infections such as genital herpes. Antiviral medications are used to manage symptoms and reduce recurrences.
Choice C rationale
This is the most appropriate response. While there is no cure for genital herpes, antiviral medications can help to reduce symptoms and the frequency of recurrences.
Choice D rationale
Having a genital herpes infection does not lead to immunity. The virus remains in the body and can cause recurrent outbreaks.
Correct Answer is D
Explanation
Choice A rationale
The American Cancer Society does not recommend starting mammograms at age 30 for women at average risk. This age is too young for the initiation of routine screening mammograms.
Choice B rationale
The American Cancer Society does not recommend starting mammograms at age 35 for women at average risk. This age is still considered too young for the initiation of routine screening mammograms.
Choice C rationale
The American Cancer Society does not recommend starting mammograms at age 40 for women at average risk, although women between 40 and 44 have the option to start screening with a mammogram every year.
Choice D rationale
According to the American Cancer Society, women at average risk should start having mammograms at age 45. From age 45 to 54, they should get mammograms every year.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.